V2X Awarded $170 Million Contract to Support DEA's Mission in Combating Drug Trafficking and Enhancing National Security

30.12.24 13:28 Uhr

Werte in diesem Artikel

RESTON, Va., Dec. 30, 2024 /PRNewswire/ -- V2X, Inc. (NYSE: VVX) is proud to announce the award of a $170 million contract to continue its critical support of the Drug Enforcement Administration's (DEA) fleet of over 100 aircraft. This award reinforces V2X's commitment to enabling the DEA's vital mission against the war on drugs and protecting national security.

V2X (PRNewsfoto/V2X, Inc.)

"V2X has consistently demonstrated a complete understanding of the DEA's mission, and the flexibility required to support its special mission aircraft and pilot development," said Jeremy C. Wensinger, President and CEO of V2X. "This award reflects the trust placed in our team to deliver high-impact solutions that empower the DEA to combat drug trafficking and safeguard national security."

V2X has been steadfast in supporting this vital mission since 1997 and this five-year contract will ensure continued operational readiness for the DEA's aircraft fleet. V2X remains dedicated to advancing national security by leveraging its decades of experience and innovative solutions to support critical missions.

About V2X
V2X builds innovative solutions that integrate physical and digital environments by aligning people, actions, and technology. V2X is embedded in all elements of a critical mission's lifecycle to enhance readiness, optimize resource management, and boost security. The company provides innovation spanning national security, defense, civilian, and international markets. With a global team of approximately 16,000 professionals, V2X enables mission success by injecting AI and machine learning capabilities to meet today's toughest challenges across all operational domains.

Media Contact
Angelica Spanos Deoudes 
Senior Director, Marketing and Communications
Angelica.Deoudes@goV2X.com 
571-338-5195

Investor Contact
Mike Smith, CFA 
Vice President, Treasury, Corporate Development and Investor Relations 
IR@goV2X.com 
719-637-5773

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/v2x-awarded-170-million-contract-to-support-deas-mission-in-combating-drug-trafficking-and-enhancing-national-security-302339885.html

SOURCE V2X, Inc.

Ausgewählte Hebelprodukte auf Vectrus

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Vectrus

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Vectrus Inc When Issued

Wer­bung

Analysen zu Vectrus Inc When Issued

DatumRatingAnalyst
26.06.2019Vectrus BuyB. Riley FBR
21.11.2017Vectrus HoldStifel, Nicolaus & Co., Inc.
30.09.2016Vectrus HoldStifel, Nicolaus & Co., Inc.
21.05.2015Vectrus HoldStifel, Nicolaus & Co., Inc.
18.03.2015Vectrus Fair ValueCRT Capital
DatumRatingAnalyst
26.06.2019Vectrus BuyB. Riley FBR
21.11.2017Vectrus HoldStifel, Nicolaus & Co., Inc.
30.09.2016Vectrus HoldStifel, Nicolaus & Co., Inc.
21.05.2015Vectrus HoldStifel, Nicolaus & Co., Inc.
18.03.2015Vectrus Fair ValueCRT Capital
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Vectrus Inc When Issued nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"